Perioperative Systemic Inflammation in Lung Cancer Surgery

Area of Science:

• Immunology
• Surgical Oncology
• Anesthesiology

Background:

• Systemic inflammation (SI) is a critical immune response to injury, including surgical trauma.
• Postoperative SI affects innate and adaptive immunity, influencing patient recovery and tumor cell dynamics.
• Elevated inflammatory cytokines perioperatively can negatively impact immune therapy efficacy and survival.

Purpose of the Study:

• To review the impact of surgical factors on postoperative systemic inflammation and immune defense in lung cancer surgery.
• To explore how different surgical techniques and anesthesia influence the inflammatory response.
• To highlight the clinical relevance of managing SI for improved patient outcomes.

Main Methods:

• Review of current knowledge on operative factors affecting postoperative SI.
• Analysis of the interplay between surgical damage, immune response, and clinical outcomes.
• Discussion of minimally invasive surgery, spontaneous ventilation, and locoregional anesthesia effects.

Main Results:

• Surgical intervention consistently triggers SI, with intensity correlating to damage extent.
• Minimally invasive thoracic surgery and spontaneous ventilation reduce SI and immune suppression compared to open surgery.
• Lower cytokine levels post-lung surgery correlate with reduced morbidity (e.g., pneumonia, infection).

Conclusions:

• Operative factors significantly modulate postoperative SI and immune function in lung cancer patients.
• Minimally invasive techniques, spontaneous ventilation, and locoregional anesthesia can mitigate SI.
• Managing SI is crucial for reducing postoperative morbidity and potentially improving cancer treatment outcomes.